Anemia Associated With Chronic Kidney Disease (CKD)

2 clinical trials · Condition

Record	Firm	Date
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects (NCT04707768)	Akebia Therapeutics	2021-06-18

Every clearance here is in the API, with alerts when new ones post.